Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Merge Healthcare's Net Income for the
three
months ended in Jun. 2015 was €1.8 Mil. Its Net Income for the trailing twelve months (TTM) ended in Jun. 2015 was €20.7 Mil.
The historical data trend for Merge Healthcare's Net Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.
Net Income for the trailing twelve months (TTM) ended in Jun. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €20.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merge Healthcare (FRA:MRJ) Net Income Explanation
Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
EPS is most useful for companies that have:
A predictable business
Consistent accounting methods
And few restructurings
The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
Merge Healthcare Net Income Related Terms
Thank you for viewing the detailed overview of Merge Healthcare's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Merge Healthcare Inc is a Delaware corporation founded in 1987. The Company develops enterprise imaging software solutions that facilitate the management of images to create a more effective and efficient electronic healthcare experience for patients and physicians. Its solutions are designed to help solve some of the difficult challenges in health information exchange today, such as the incorporation of medical images and diagnostic information into broader healthcare IT applications, the interoperability of proprietary software solutions, and the ability to improve the efficiency and cost effectiveness of its customers businesses. The Companys solutions optimize processes for healthcare providers ranging in size from single provider practices to large health systems, to the sponsors of clinical trials and medical device manufacturers. It operates in two reportable segments: Merge Healthcare mainly generates revenue from the sale of software including upgrades; hardware, professional services, maintenance and electronic data interchange services. Merge DNA derives the vast majority of its revenue from software, professional services and hosting through subscription arrangements. Its product portfolio provides products and services to its customers, including Image Interoperability Platform iConnect: This interoperability and connectivity platform enables hospitals, imaging centers, Integrated Delivery Networks and Health Information Exchanges to create information exchanges within their environments and with other entities.,Clinical and Financial Information Systems - Digital Imaging Solutions: Picture Archiving and Communication Systems, specialty workstations and related applications manage the image workflow of a medical enterprise; Clinical information systems: These systems provide a complete electronic record of a medical procedure across a variety of specialties including Merge OrthoEMR for orthopaedics, and Merge RIS for radiology; Revenue Cycle Management: It offer software and services for the revenue cycle management of physician practices, Software Development Toolkits, Technologies and Platforms - Merge toolkits, technologies and platforms provide software developers with the necessary resources to assist in the timely development of new products and enhance existing products and Hosted Software Solutions for Clinical Trial Data Management It provide hosted software solutions for the collection, aggregation, analysis, reporting and overall management of clinical trials information. Its strategy is to be a provider of integrated, healthcare IT solutions and services that improve the exchange of healthcare information. It is subject to regulation in the U.S. by the Food and Drug Administration, including periodic FDA inspections, in Canada under Health Canadas Medical Devices Regulations, and in other countries by corresponding regulatory authorities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:MRJ has been successfully added to your 